Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.47
Bid: 3.52
Ask: 3.98
Change: 0.00 (0.00%)
Spread: 0.46 (13.068%)
Open: 3.47
High: 0.00
Low: 0.00
Prev. Close: 3.47
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Technology Update

28 Nov 2018 07:00

RNS Number : 6896I
Plant Health Care PLC
28 November 2018
 

28 November 2018

 

PLANT HEALTH CARE plc

 

 

("Plant Health Care" or the "Company")

 

 

New Technology Update 

 

 

Plant Health Care®, a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to provide the following update in relation to its New Technology business in corn and soy crops.

 

Highlights:

- Plant Health Care's novel PREtec (Plant Response Elicitor Technology) has very large potential in the more than 375 million acres of corn and soy planted in North America, Brazil and Argentina.

- Three more global agricultural/seed companies have signed agreements to evaluate Plant Health Care's PREtec product candidates on multiple crops on three continents.

- These new collaborators are seeking novel, low toxicity biological products such as PREtec, to enable farmers to be more productive with lower environmental impact.

- Plant Health Care is continuing field trials with the Company's Innatus 3G peptide PHC279 against Asian Soybean Rust (ASR) in Brazil.

 

PREtec is a novel, environmentally friendly approach to protecting crops, based on peptides derived from natural proteins. These proprietary peptides are stable and compatible with mainstream agriculture practices. By activating the innate growth and defence mechanisms of plants, PREtec peptides lead to higher crop yields and better protection against disease and environmental stresses such as drought.

 

Corn and soy are major targets for PREtec. They are grown on more than 375 million acres in North and South America. A yield increase of just 2% brings a soybean farmer in Brazil almost an additional $10 per acre; in the USA it brings a corn (maize) farmer almost $13 per acre. Plant Health Care's evaluation partners supply most of the leading corn and soy seed treatments.

 

PREtec peptides can also reduce the corn yield losses caused by drought stress during critical growth stages. Under the drought conditions of the Company's field trials, corn plants whose seeds were treated with PREtec increased yield by an average of almost 17% over three consecutive growing seasons compared to untreated plants.

 

Three additional global agricultural companies have now signed agreements to evaluate several platforms of the PREtec technology. These companies join existing evaluation partners, who are looking for novel technology that will boost yield in row crops and have a safe environmental profile while solving significant problems faced by growers today.

 

In the 2018/19 soybean growing season in Brazil, Plant Health Care will be conducting further trials of PHC279 against Asian Soybean Rust (ASR). Last season this product did not deliver a decisive impact on disease symptoms as a foliar spray, but did show yield improvements. This season, trials will assess the economic value of PHC279 seed treatment and early season sprays.

 

Chris Richards, Executive Chairman & Interim CEO, said "As we continue to generate positive results from our PREtec platform of peptides, we are delighted to expand our range of partners who will evaluate our technology on multiple crops in multiple regions during the 2019 growing season."

 

For further information, please contact:

 

Plant Health Care plc

 

Chris Richards, Executive Chairman and Interim CEO

 

Tel: +1 919 926 1600

Arden Partners plc (Nomad and Broker)

John Llewellyn-Lloyd

 

Dan Gee-Summons

Tel: +44 (0) 20 7614 5900

 

IFC Advisory (Financial PR)

 

Graham Herring

 

Miles Nolan

 

Zach Cohen

Tel: +44 (0) 20 3934 6630

 

 

 

Company website: www.planthealthcare.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDPGGCGGUPRGBM
Date   Source Headline
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments
12th Jan 20237:00 amRNSNovozymes Distribution Agreement
9th Jan 20237:00 amRNSInvestor Presentation
22nd Dec 20227:00 amRNSNew Products Submitted for Regulatory Approval
28th Oct 20227:00 amRNSRegistration of Harpin in France

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.